Search | Proceedings | Concurrent Oral Session Grid | Author Index | eBook

Author Index: F

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Fagerlin, A.
G-1   BLOCKS, OVALS, OR PEOPLE: DOES ICON TYPE IN PICTOGRAPHS INFLUENCE THE CORRELATION BETWEEN PERCEIVED AND ACTUAL RISK?,
G-4   DOES KEEPING IT SIMPLE ACTUALLY HELP? TESTING THE IMPACT OF THE READING LEVEL OF A DECISION AID ON PROSTATE CANCER DECISION MAKING,
G-6   DETERMINING THE RELATIONSHIP BETWEEN PATIENT LITERACY AND THE DECISION MAKING EXPERIENCE OF PATIENTS WITH PROSTATE CANCER,
J-6   ANXIETY AND ACTION BIAS AS PREDICTORS OF PROSTATE CANCER TREATMENT PREFERENCES AND TREATMENT DECISIONS,
P1-28   ON STRATEGIES TO CONTROL HEALTHCARE COSTS: INFLUENCING PATIENTS TO “SELF-RATION” BY COMMUNICATING THE SOCIAL IMPLICATIONS OF OVERUSE,
P2-22   A TARGETED DECISION AID FOR MINORITY PARTICIPATION IN CANCER CLINICAL TRIALS: EFFECT ON KNOWLEDGE, PREPAREDNESS FOR DECISION-MAKING, SELF-EFFICACY, AND WILLINGNESS TO PARTICIPATE,
P3-5   REACTIONS TO A TARGETED DECISION AID FOR MINORITY PARTICIPATION IN CANCER CLINICAL TRIALS AND ITS EFFECT ON ATTITUDES TOWARDS PARTICIPATION,
P3-51   PATIENT DISCORDANCE BETWEEN SURGERY CHOICE AND TREATMENT-RELATED VALUES: A PRELIMINARY STUDY OF BARIATRIC PATIENTS,
TRA1-2   WHAT'S IN A NAME? THE INFLUENCE OF A DISEASE LABEL ON A PARENT'S DECISION TO MEDICATE A FUSSY BABY
Fagerlin, A.
TRA1-4   MODELING PERSONALIZED RANK ORDER OF PREVENTIVE CARE GUIDELINES
Falzer, P. R.
P1-21   WILLINGNESS TO CHANGE TREATMENT SHOULD BE ASSESSED AT MULTIPLE TIME POINTS,
P4-11   PREDICTORS OF TREATMENT ESCALATION IN CLINICAL PRACTICE
Fang, Y.
P1-13   COST-EFFECTIVENESS OF ENHANCED DEPRESSION CARE FOR PATIENTS WITH ACUTE CORONARY SYNDROME AND DEPRESSIVE SYMPTOMS: RESULTS OF THE COPES RANDOMIZED CONTROLLED TRIAL
Farnham, P. G.
F-4   COST-EFFECTIVENESS OF MORE FREQUENT HIV SCREENING OF POPULATIONS AT RISK,
P1-15   ESTIMATING LIFETIME HIV TREATMENT COSTS IN THE UNITED STATES: EARLY VERSUS LATE ENTRY INTO CARE
Farr, A.
P1-39   PATTERNS AND CORRELATES OF LINKAGE TO APPROPRIATE HIV CARE FOLLOWING HIV DIAGNOSIS IN THE UNITED STATES MEDICAID POPULATION
Faruque, S.
P1-2   COST-EFFECTIVENESS OF ROUTINE USE OF MAGNESIUM SULFATE FOR SEIZURE PROPHYLAXIS IN MILD PREECLAMPSIA,
P2-48   DETERMINING OPTIMAL INFORMATIONAL INTERVENTION BUNDLES TO MAXIMIZE HEALTH OUTCOMES
Federspiel, J. J.
B-4   REFERRAL BIAS IN THE DIAGNOSTIC PERFORMANCE OF EXERCISE TESTING WITH IMAGING FOR CORONARY ARTERY DISEASE
Feeny, D.
P3-13   IMPACT OF CAREGIVER STATUS ON HEALTH STATE VALUATIONS
Feeny, N.
P2-13   COST-EFFECTIVENESS ESTIMATES IN A DOUBLY RANDOMIZED PREFERENCE DESIGN,
P3-6   DETERMINING MINIMAL CLINICALLY IMPORTANT DIFFERENCE FOR THE PREFERENCE-BASED INSTRUMENTS EUROQOL (EQ-5D) AND QUALITY OF WELL-BEING (QWB) IN POST-TRAUMATIC STRESS DISORDER (PTSD) PATIENTS,
P4-6   COST-EFFECTIVENESS OF TREATMENT EFFECT AND TREATMENT-PREFERENCE EFFECT OF COGNITIVE BEHAVIORAL THERAPY VERSUS PHARMACOTHERAPY IN POST-TRAUMATIC STRESS DISORDER (PTSD)
Feibelmann, S.
P1-25   RESULTS FROM A DECISION MAKING SURVEY OF LATINA BREAST CANCER PATIENTS
Feinberg, B.
P1-18   DETERMINANTS OF COUNSELING REGARDING TRIAL OF LABOR AFTER CESAREAN: THE IMPACT OF PROVIDER CHARACTERISTICS,
P3-27   CLINICIAN ACCURACY IN PREDICTING SUCCESSFUL VAGINAL BIRTH AFTER CESAREAN: IMPACT OF PATIENT CHARACTERISTICS ON PROVIDER COUNSELING
Feldman-Stewart, D.
P2-28   DECISION SUPPORT NEEDS TO BE TAILORED TO THE INDIVIDUAL PATIENT: ADJUVANT ENDOCRINE THERAPY FOR POST-MENOPAUSAL WOMEN WITH RECEPTOR-POSITIVE EARLY-STAGE BREAST CANCER
Ferdjaoui-Moumjid, N.
P2-29   INTERNATIONAL WORKING GROUP ON CORE COMPETENCIES FOR TRAINING HEALTH PROFESSIONALS IN SHARED DECISION MAKING HIGHLIGHTS THE HETEROGENEITY OF CURRENT PROGRAMS
Ferket, B. S.
P1-32   MODELING THE ADDED PREDICTIVE VALUE OF A NOVEL CARDIOVASCULAR RISK MARKER WITH A SIMPLE MARKOV MODEL,
P2-51   ITERATIVE CALIBRATION OF MONTE-CARLO MARKOV MODELS USED FOR EVALUATING THE IMPACT OF UPDATING TRADITIONAL CARDIOVASCULAR RISK PREDICTIONS WITH NOVEL RISK MARKERS
Ferron Parayre, A.
P2-15   THE SURE TOOL: SCREENING FOR DECISIONAL CONFLICT IN PRIMARY CARE
Ferziger, R.
P3-20   A TALE OF TWO TRIAL DESIGNS: EVALUATION OF EFFICACY VS EFFECTIVENESS IN SCHIZOPHRENIA
Finelli, A.
A-3   RADICAL SURGERY VERSUS RADICAL RADIATION FOR ADVANCED BLADDER CANCER: A DECISION ANALYSIS
Fisher, C. R.
D-2   AN INTELLIGENT TUTORING SYSTEM TO HELP WOMEN DECIDE ABOUT TESTING FOR GENETIC BREAST CANCER RISK,
P1-48   MULTIPLE SIGNAL DETECTION APPLIED TO GIST-BASED DISCRIMINATION OF GENETIC RISK IN BREAST CANCER
Fisman, D. N.
F-2   SCREEN MORE OR SCREEN MORE OFTEN? USING MATHEMATICAL MODELS TO INFORM SYPHILIS CONTROL STRATEGIES
Fleischmann, K. E.
P1-32   MODELING THE ADDED PREDICTIVE VALUE OF A NOVEL CARDIOVASCULAR RISK MARKER WITH A SIMPLE MARKOV MODEL,
P2-51   ITERATIVE CALIBRATION OF MONTE-CARLO MARKOV MODELS USED FOR EVALUATING THE IMPACT OF UPDATING TRADITIONAL CARDIOVASCULAR RISK PREDICTIONS WITH NOVEL RISK MARKERS
Flemons, W. W.
P1-29   PHYSICIAN OVERUTILIZATION OF SLEEP STUDIES IN PREDICTING PATIENT IMPROVEMENT USING CPAP
Flum, D. R.
P2-46   AUTOMATING CLINICAL DATA EXTRACTION TO SUPPORT COMPARATIVE EFFECTIVENESS RESEARCH
Fong, R. K.
P2-36   CHOLINESTERASE INHIBITORS: A POPULATION-BASED ASSESSMENT OF RESOURCE UTILIZATION FOR PATIENTS WITH ALZHEIMER'S DEMENTIA
Fontanesi, J.
P4-55   IDENTIFYING OPERATIONAL FACTORS AFFECTING PATIENTS' UNDERSTANDING OF TREATMENT
Fosburgh, B. W.
P3-9   OPTIMIZING OUTPATIENT RESIDENCY TRAINING: BALANCING CLINICAL EXPERIENCE WITH ACCESS TO CARE
Fox, D.
P4-22   PEDIATRIC ENTERAL ACCESS PROCEDURES IN THE U.S.: REGIONAL VARIATION AND CHANGING RATES
Fraenkel, L.
G-2   WHY DO I KNOW MORE ABOUT THE LOTTO THAN I DO ABOUT MY MEDICATIONS? NUMBERS MATTER TO INFORMED PATIENT CHOICES,
P1-21   WILLINGNESS TO CHANGE TREATMENT SHOULD BE ASSESSED AT MULTIPLE TIME POINTS,
P2-24   PATIENTS' PREFERENCES TO INFORM DRUG DEVELOPMENT,
P3-15   WHEN DO PHYSICIANS RECOMMEND JOINT REPLACEMENT FOR PATIENTS WITH MODERATE DISEASE?,
P4-11   PREDICTORS OF TREATMENT ESCALATION IN CLINICAL PRACTICE
Franco, O. H.
P1-32   MODELING THE ADDED PREDICTIVE VALUE OF A NOVEL CARDIOVASCULAR RISK MARKER WITH A SIMPLE MARKOV MODEL,
P2-51   ITERATIVE CALIBRATION OF MONTE-CARLO MARKOV MODELS USED FOR EVALUATING THE IMPACT OF UPDATING TRADITIONAL CARDIOVASCULAR RISK PREDICTIONS WITH NOVEL RISK MARKERS
Fraser, G.
D-5   NOVEL METHODS TO OVERCOME HEALTH LITERACY BARRIERS TO SHARED DECISION MAKING IN PROSTATE CANCER AMONG LOW-INCOME AFRICAN AMERICAN MEN
Fraser, K.
P2-30   HEALTHCARE PROVIDERS' INTENTIONS TO ENGAGE IN AN INTERPROFESSIONAL APPROACH TO SHARED DECISION MAKING IN HOME CARE PROGRAMS: A MIXED METHODS STUDY
Frederiksen, S.
P4-37   ECONOMIC BENEFIT OF AN EDUCATIONAL INTERVENTION TO IMPROVE TPA USE IN COMMUNITY HOSPITALS
Freedberg, K. A.
K-5   COST-EFFECTIVENESS ANALYSIS OF UGT1A1 GENETIC TESTING TO INFORM INITIAL ANTIRETROVIRAL PRESCRIBING FOR TREATMENT OF HIV IN THE US
Frick, K. D.
P1-60   COST-EFFICIENT DESIGN OF EPIDEMIOLOGICAL STUDIES USING DISCRETE EVENT SIMULATION MODEL – EPISOL STUDY SIMULATOR 1.0
Friedrich, G.
P2-29   INTERNATIONAL WORKING GROUP ON CORE COMPETENCIES FOR TRAINING HEALTH PROFESSIONALS IN SHARED DECISION MAKING HIGHLIGHTS THE HETEROGENEITY OF CURRENT PROGRAMS
Frimpter, J.
H-2   META-ANALYSIS OF REAL-WORLD STUDIES OF INITIATING INSULIN GLARGINE VIA DISPOSABLE PEN VERSUS VIAL/SYRINGE AMONG PATIENTS WITH TYPE 2 DIABETES: APPLYING A COMMON DATA STRUCTURE TO A UNIQUE EVIDENCE SYNTHESIS PLATFORM
Frosch, D.
P1-27   DEVELOPING A THEORY-BASED MEASURE OF PATIENT SHARED DECISION MAKING COMMUNICATION BEHAVIORS,
P3-1   THE IMPLEMENTATION OF PATIENT DECISION SUPPORT INTERVENTIONS INTO ROUTINE CLINICAL PRACTICE: A SYSTEMATIC REVIEW
Fuhrel-Forbis, A.
G-1   BLOCKS, OVALS, OR PEOPLE: DOES ICON TYPE IN PICTOGRAPHS INFLUENCE THE CORRELATION BETWEEN PERCEIVED AND ACTUAL RISK?
Fukushima, H.
P2-27   DEVELOPMENT AND EVALUATION OF THE “EMERGENCY MEDICAL ALLIANCE FOR TOTAL COODINATION IN HEALTHCARE (E-MATCH)” TO PROMOTE SHARED DECISION MAKING BETWEEN EMTS AND MEDICAL FACILITIES
Fulcher, N.
P1-39   PATTERNS AND CORRELATES OF LINKAGE TO APPROPRIATE HIV CARE FOLLOWING HIV DIAGNOSIS IN THE UNITED STATES MEDICAID POPULATION
Furman, A. E.
P3-39   STAKEHOLDER INPUT TO CLINICAL DECISION SUPPORT (CDS) FOR COMPLEX CHRONIC DISEASE
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z